Investing.com: Why Investors Should Track The Prescription Drug User Fee Act
Link to article on investing.com: https://www.investing.com/analysis/why-investors-should-track-the-prescription-drug-user-fee-act-200583708
Summary:
DUFA dates and content are essential for portfolio managers of healthcare stocks. A single positive or negative announcement from the US Food and Drug Administration (FDA) can send shares of a biotech firm soaring or turn a hot name quickly into a bear market. Among the dozens of corporate event data points provided to our customers, Wall Street Horizon gathers PDUFA dates and content so our clients stay in the know.
Recent Content
-
What’s the Next Financial Shoe to Drop? Eyeing a Late Earnings Date Confirmation
-
FactSet Insight: March Investor and Analyst Days
-
Investor Day Month: Key Analyst Days Happening in March
-
FlexTrade: Macro-Data Drives Hedge Fund Strategies
-
Signs Point Towards Not So Rosy Outlooks from Retailers
-
FactSet Insight: Despite Robust January Retail Sales There Are Signs That Outlooks From Retailers Won’t Be So Rosy
-
A Pair of Bullish Earnings Date Confirmation Stocks and A Bearish Late Retail Confirmer
-
Investor's Business Daily: 7 Stocks Generate An Astounding 25% Of The S&P 500's Profit
-
See It Market: 2023 ETF Trends - What Investors Should Look Out For
-
Earnings Growth Improves as Investors Ready Themselves for Retailers
